JPRN-UMIN000025675已完成1 期
Observational study of neoadjuvant GS chemotherapy for patients with pancreatic cancer - Neoadjuvant GS chemotherapy for pancreatic cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients with lung fibrosis and/or interstitial pneumoniae 2)unresectable SMA invasion 3)active double cancer 4)active infectious disease 5)creatinine clearance < 30mL/min
研究者
相似试验
已完成
2 期
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma (NAC GS2+2)resectable pancreatic cancerJPRN-UMIN000009070EXTSURG35
已完成
2 期
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 (GS therapy) for resectable pancreatic carcinoma (NAC GS3)resectable pancreatic cancerJPRN-UMIN000003402Miyagi HBPCOG35
已完成
2 期
Phase II study of Neoadjuvant chemotherapy with Gemcitabine and S1 for resectable pancreatic carcinomaresectable pancreatic cancerJPRN-UMIN000004148Study group of preoperative therapy for pancreatic cancer (Prep)80
招募中
2 期
The phase 2 study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel+S-1 for patients with biological borderline resectable pancreatic cancer.Pancreatic ductal adenocarcinomaJPRN-UMIN000030717Department of gastrointestinal Surgery, Hiroshima University Hospital50
招募中
2 期
The phase 2 study of neoadjuvant chemotherapy of GAS for biological borderline resectable pancreatic cancer.Biological borderline resectable pancreatic cancerJPRN-jRCTs061180009emura Kenichiro50